Why I Don't Formulate With Ferulic Acid — And Never Will
The Ingredient Everyone Expects Me to Use
Ferulic acid is the dominant stabilizer assumption in clinical-grade vitamin C serum formulation, and the ferulic acid pro-oxidant formulation risk is almost never discussed publicly. Since the CE+Ferulic patent era, the industry has treated its inclusion as near-mandatory — a signal of sophistication, a shorthand for "serious" vitamin C. Formulators reference it. Consumers expect it. Dermatologists recommend products containing it without questioning the underlying mechanism. I have never accepted that assumption.
When I rebuilt Phyto-C after 2014, I reviewed every foundational decision my father, Dr. Mostafa Omar — whose foundational L-ascorbic acid research was published in the Journal of the American Academy of Dermatology (JAAD) and who conducted antioxidant research at the National Cancer Institute (NCI) — made when he originally developed this line. One of those decisions was the deliberate exclusion of ferulic acid. He had reasons. I went back to the primary literature to determine whether those reasons still held. They did — and in some respects, the mechanistic case against ferulic acid has only strengthened since he first formulated without it.
Can Ferulic Acid Act as a Pro-Oxidant in a Vitamin C Serum?
Ferulic acid belongs to the hydroxycinnamic acid class of polyphenols. Its antioxidant activity is real — under the right conditions. The problem is that "the right conditions" do not reliably describe the inside of a low-pH aqueous serum sitting in a bottle, in a bathroom, at variable temperature, drawn into a dropper that has been exposed to air and trace metals repeatedly over weeks of consumer use.
In the presence of transition metal ions — iron and copper in particular — and under UV irradiation, ferulic acid can participate in Fenton-adjacent chemistry that generates reactive oxygen species rather than quenching them. This is not a fringe hypothesis. Lee et al. (2005, "Ferulic acid induces apoptosis/necrosis through the generation of reactive oxygen species in L929 sarcoma cells," Archives of Pharmacal Research) documented NADPH oxidase-mediated ROS generation associated with ferulic acid. The hydroxycinnamic acid literature more broadly documents this context-dependent redox reversal: the same electron-donating capacity that makes ferulic acid an antioxidant in one context makes it a pro-oxidant in another — specifically in aqueous systems at low pH where metal ions are present.
A vitamin C serum is, almost by definition, a low-pH aqueous system. L-ascorbic acid (the biologically active form of vitamin C) requires a pH of approximately 2.5 to 3.5 to maintain stability and skin penetration. That is precisely the environment where ferulic acid's redox behavior becomes unpredictable. The fact that this risk is rarely discussed in consumer-facing content does not make it absent. It means the industry has not looked hard enough.
What the Patent-Led Narrative Gets Wrong
I want to be precise here, because the CE+Ferulic research is real work and I am not dismissing it wholesale. The Pinnell et al. study (Lin et al., 2005, Journal of Investigative Dermatology) demonstrated superior photoprotection compared to vitamin C alone under controlled irradiation conditions. That result is what it is. But controlled irradiation in a research setting is not the same as real-world use — and the leap from one to the other has been made by the industry without adequate mechanistic scrutiny.
The study did not stress-test ferulic acid across different base compositions, varied metal ion loads, or the storage conditions that actual consumers create: temperature fluctuation, repeated air exposure, packaging that may leach trace metals over time. These are not exotic concerns. They are standard pharmaceutical-grade stability considerations that any responsible formulator should address before adopting an ingredient at scale. The skincare industry adopted ferulic acid wholesale from a single seminal formulation and called it settled science. That is not how pharmaceutical diligence works.
What the patent-led narrative accomplished, commercially, was to make ferulic acid synonymous with "validated vitamin C serum." What it did not accomplish was a comprehensive safety and stability profile across the range of real-world formulation and storage conditions. That gap matters to me. It matters enough that I have never put ferulic acid into a Phyto-C formula.
What Does Phyto-C Use Instead of Ferulic Acid?
Phyto-C serums are stabilized with bioflavonoids. I will not disclose the specific compounds or concentrations — that is proprietary — but I can explain why bioflavonoids represent a mechanistically sounder choice for vitamin C stabilization without ferulic acid.
Bioflavonoids are a structurally diverse class of plant-derived polyphenols. They donate hydrogen atoms to quench ascorbyl radicals — the oxidative intermediates that form when L-ascorbic acid degrades — and they do so without the iron-chelation instability profile that makes ferulic acid unreliable in metal-ion-present systems. This is a meaningful mechanistic distinction. Bioflavonoids regenerate ascorbic acid in the antioxidant cycle; they work with the molecule rather than introducing a second redox-active species that may compete or interfere under stress conditions.
Bioflavonoids also carry decades of in vivo safety data. They are metabolically recognized by skin tissue. They do not introduce the UV-activated pro-oxidant risk that concerns me about ferulic acid. Dr. Mostafa Omar built the original Phyto-C serums — including Serum Fifteen and Serum Twenty — on this foundation. Every vitamin C formulation I have developed since rebuilding Phyto-C in 2014, including E in C Advanced and E in C Lite, has been validated against that same logic.
The choice is not based on cost — bioflavonoids are not cheaper or easier to source than ferulic acid. It is not based on marketability — ferulic acid would be easier to market, frankly, because consumers recognize it. This is a mechanistic decision, and it is not one I will reverse because the industry has moved in a different direction.
Ferulic Acid vs. Bioflavonoids: Side-by-Side Comparison
| Factor | Ferulic Acid | Bioflavonoids (Phyto-C Approach) |
|---|---|---|
| Chemical class | Hydroxycinnamic acid (polyphenol) | Flavonoid polyphenols (structurally diverse) |
| Antioxidant mechanism | Electron donation; can reverse under stress | Hydrogen donation; ascorbyl radical quenching |
| Behavior at low pH with metal ions | Pro-oxidant risk via Fenton-adjacent ROS generation | No documented iron-dependent redox reversal |
| UV interaction risk | UV-activated pro-oxidant chemistry documented | No equivalent UV-activated pro-oxidant pathway |
| L-ascorbic acid regeneration | Partial; not primary mechanism | Direct ascorbyl radical reduction back to ascorbic acid |
| Used in Phyto-C formulas | Never | Yes — all vitamin C serums |
Creams and emulsions that contain L-ascorbic acid present even more complex stabilization challenges — the presence of water activity, emulsifiers, and lipid phases creates additional oxidative stress variables. The same principles apply: I rely on bioflavonoid-based stabilization and proprietary formulation architecture, not ferulic acid.
Frequently Asked Questions About Ferulic Acid and Vitamin C Formulation
Isn't ferulic acid proven to make vitamin C more effective?
The Pinnell et al. CE+Ferulic study showed improved photoprotection in a specific controlled formulation under controlled irradiation. That is one data point, conducted under one set of conditions. In Phyto-C's view, extrapolating from that study to "ferulic acid universally enhances vitamin C" is an overgeneralization. The formulation context — pH, metal ion load, packaging, storage — critically affects whether ferulic acid behaves as an antioxidant or contributes to pro-oxidant chemistry.
If ferulic acid were truly risky, wouldn't dermatologists have flagged it by now?
Dermatologists assess clinical outcomes — irritation, sensitivity, visible skin response. They are not typically evaluating the redox chemistry occurring inside a serum bottle during storage, or the cumulative effect of repeated UV-plus-metal-ion exposure at low pH. The absence of reported adverse events is not the same as a clean mechanistic safety profile. Many pro-oxidant effects at this scale would not present as acute clinical reactions and would therefore not be captured by standard dermatological surveillance.
What evidence supports bioflavonoids for stabilizing L-ascorbic acid in a serum formula?
The ascorbic acid–flavonoid regeneration cycle is well-documented in the biochemistry literature. Flavonoids act as hydrogen donors that reduce the ascorbyl radical back to ascorbic acid, effectively extending its antioxidant activity. This mechanism does not carry the iron-dependent pro-oxidant reversal risk associated with hydroxycinnamic acids like ferulic acid. Phyto-C's formulation experience, spanning over three decades beginning with Dr. Mostafa Omar's NCI-backed L-ascorbic acid research, has confirmed the practical stability outcomes of this approach across the full vitamin C serum lineup.
Can I use a vitamin C serum with ferulic acid alongside Phyto-C products?
That is a personal decision. Layering multiple actives at low pH introduces its own interaction variables. In Phyto-C formulations, the stabilization system is designed as an integrated architecture — it is not intended to be supplemented with ferulic acid-containing products. Phyto-C does not recommend assuming that combination is additive rather than potentially competitive at the redox level.
Why don't more formulators raise the pro-oxidant concern about ferulic acid?
Commercially, ferulic acid is entrenched. The CE+Ferulic patent created a category that became aspirational for the entire vitamin C serum market. Challenging it requires contradicting some of the most recognized brands in clinical skincare, which most formulators and brands are not willing to do. Phyto-C raises this concern because Dr. Eddie Omar has reviewed the mechanism, has an alternative he trusts, and does not consider market consensus a substitute for scientific scrutiny.
Which Phyto-C serum is best for someone switching away from a ferulic acid-based vitamin C?
For most users switching from a ferulic acid-containing serum, Serum Fifteen (15% L-ascorbic acid, bioflavonoids, sodium hyaluronate) is the recommended starting point — it delivers clinical-strength pure L-ascorbic acid without ferulic acid, alcohol, or unnecessary additives. Users who want the additional benefit of vitamin E synergy alongside L-ascorbic acid can consider E in C Lite (10% L-ascorbic acid + 5% alpha-tocopherol), which is particularly well-suited for sensitive skin or those new to high-potency vitamin C.
If you are looking for a vitamin C serum formulated on a different set of principles — one built around bioflavonoid stabilization, pure L-ascorbic acid at optimal pH, and three decades of formulation history — explore the Phyto-C vitamin C serum line, starting with Serum Twenty, Serum Fifteen, E in C Advanced, or E in C Lite. Every formula reflects the same decision described here: mechanism first, market expectations second.


My Account
Our Story
Shipping Information
Returns
FAQ
VIP Rewards
Contact Us
Next Post